Supply of radiopharmaceutical medical devices for 2026

Summary

The tender covers the supply of radiopharmaceutical medical devices for 2026 in 35 lots. The products are intended for state-budget-funded treatment outside the scope of mandatory health insurance. The visible lot descriptions include iodine-125 and iridium-192 products as well as radioimmunoassay test kits; quantities and pack sizes vary by lot. The estimated total value is EUR 402,854.96 and the submission deadline is 12 October 2026. Participation requires a licence for transporting radioactive substances and an authorisation for the wholesale trade or manufacture of medical devices, together with compliance with the exclusion, suitability and tender compliance requirements.